Literature DB >> 7419681

A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum.

T Tanaka, R P Shiu, P W Gout, C T Beer, R L Noble, H G Friesen.   

Abstract

The replication of Nb 2 Node rat lymphoma cells in suspension culture is specifically stimulated by lactogenic hormones. Human (hPRL), ovine, bovine, and rat PRLs stimulated replication in a dose-dependent manner in the concentration range of 10 pg/ml to 1 ng/ml. Human, ovine, and bovine placental lactogens were similarly active. In addition, cell replication was stimulated by human GH (hGH), which is known to have lactogenic activity. Other hormones and growth factors examined were inactive. The growth stimulatory effects of hPRL and hGH were completely inhibited when excess anti-hPRL and anti-hGH, respectively, were added to the medium. A bioassay based on the response of the Nb 2 Node lymphoma cells to lactogenic hormones has been developed. Human serum stimulated cell replication. The effect was completely abolished if excess antibodies to both hPRL and hGH were present. The stimulation obtained with a number of human serum samples correlated very well with the sum of the hPRL and hGH concentrations in the sera, as determined by RIA (r = 0.95; P < 0.001). The concentrations of either hPRL or hGH in human serum could be individually determined by specifically blocking the growth stimulatory effect of the other hormone by adding excess anti-hGH or anti-hPRl. The sensitivity of this bioassay for PRL and hGH in serum exceeds that of RIAs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7419681     DOI: 10.1210/jcem-51-5-1058

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  63 in total

1.  Prolactin family of the guinea pig, Cavia porcellus.

Authors:  S M Khorshed Alam; Toshihiro Konno; M A Karim Rumi; Yafeng Dong; Carl P Weiner; Michael J Soares
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  Immunoreactive growth hormone production by human lymphocyte cell lines.

Authors:  T L Kao; S C Supowit; E A Thompson; W J Meyer
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

3.  Comparison of Nb2 lymphoma cell bioassay with immunoassay for human prolactin: the role of estrogen.

Authors:  S Nader; M D Warner; H G Friesen; C A Peabody
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

4.  Stabilizing peptide fusion for solving the stability and solubility problems of therapeutic proteins.

Authors:  Eui Nam Lee; Young Mok Kim; Hye Ja Lee; Sang Woo Park; Han Young Jung; Jae Myun Lee; Yong-Ho Ahn; Jongsun Kim
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

5.  Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities.

Authors:  Juan J Bustamante; Alexei L Grigorian; Jesus Muñoz; Roberto M Aguilar; Lisa R Treviño; Andrew O Martinez; Luis S Haro
Journal:  Growth Horm IGF Res       Date:  2010-05-15       Impact factor: 2.372

6.  Lymphoid cell-growth hormone interactions: a serum-free model.

Authors:  J E Shaw; R Lang
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-09       Impact factor: 2.416

7.  Inhibition of Nb2 T-lymphoma cell growth by transforming growth factor-beta.

Authors:  E J Rayhel; D A Prentice; P S Tabor; W H Flurkey; R W Geib; R F Laherty; S B Schnitzer; R Chen; J P Hughes
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

8.  Bioactivity and immunoreactivity of rat pituitary prolactin submitted to various extraction procedures.

Authors:  M I Prada; H A Pasolli; A I Torres; A Aoki
Journal:  J Endocrinol Invest       Date:  1995-05       Impact factor: 4.256

9.  Hyperprolactinemia in asymptomatic patients is related to high molecular weight posttranslational variants or glycosylated forms.

Authors:  M Guitelman; M E Colombani-Vidal; C C Zylbersztein; L Fiszlejder; M Zeller; O Levalle; H E Scaglia
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

10.  Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders.

Authors:  M Bozzola; M Zecca; F Locatelli; G Radetti; S Pagani; M Autelli; L Tatò; P Chatelain
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.